Sepsis: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-msbeih@perfuse.org +msbeih@wikidoc.org, -psingh@perfuse.org +psingh13579@gmail.com, -agovi@perfuse.org +agovi@wikidoc.org, -rgudetti@perfuse.org +ravitheja.g@gmail.com, -lbiller@perfuse.org +lbiller@wikidoc.org,...) |
Hardik Patel (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sepsis}} | {{Sepsis}} | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | {{CMG}}; '''Associate Editor(s)-In-Chief:''' [[Priyamvada Singh|Priyamvada Singh, M.D.]] [mailto:psingh13579@gmail.com] | ||
{{SK}} Septicaemia | {{SK}} Septicaemia; sepsis syndrome; septic shock | ||
==[[Sepsis overview|Overview]]== | ==[[Sepsis overview|Overview]]== | ||
| Line 25: | Line 12: | ||
==[[Sepsis pathophysiology|Pathophysiology]]== | ==[[Sepsis pathophysiology|Pathophysiology]]== | ||
==[[Sepsis causes|Causes]]== | |||
==[[Sepsis differential diagnosis|Differentiating Sepsis from other Diseases]]== | |||
==[[Sepsis epidemiology and demographics|Epidemiology and Demographics]]== | ==[[Sepsis epidemiology and demographics|Epidemiology and Demographics]]== | ||
==[[Sepsis risk factors|Risk Factors]]== | ==[[Sepsis risk factors|Risk Factors]]== | ||
==[[Sepsis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ==[[Sepsis natural history, complications and prognosis|Natural History, Complications and Prognosis]]== | ||
| Line 41: | Line 28: | ||
==Treatment== | ==Treatment== | ||
[[Sepsis medical therapy|Medical Therapy]] | [[Sepsis primary prevention|Primary Prevention]] | [[Sepsis secondary prevention|Secondary Prevention]] | [[Sepsis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Sepsis future or investigational therapies|Future or Investigational Therapies]] | [[Sepsis medical therapy|Medical Therapy]] | [[Sepsis primary prevention|Primary Prevention]] | [[Sepsis secondary prevention|Secondary Prevention]] | [[Sepsis cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[Sepsis future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | ==Case Studies== | ||
[[Sepsis case study one|Case #1]] | [[Sepsis case study one|Case #1]] | ||
==Related Chapters== | ==Related Chapters== | ||
*[[Anaphylactic shock]] | *[[Anaphylactic shock]] | ||
*[[Cardiogenic shock]] | *[[Cardiogenic shock]] | ||
*[[Meningococcemia]] | *[[Meningococcemia]] | ||
*[[Neurogenic shock]] | *[[Neurogenic shock]] | ||
*[[Shock (medical)|Shock]] | *[[Shock (medical)|Shock]] | ||
*[[Systemic inflammatory response syndrome]] (SIRS) | *[[Systemic inflammatory response syndrome]] (SIRS) | ||
| Line 58: | Line 44: | ||
[[Category:Intensive care medicine]] | [[Category:Intensive care medicine]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
Revision as of 18:45, 17 December 2012
|
Sepsis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sepsis On the Web |
|
American Roentgen Ray Society Images of Sepsis |
For patient information click here
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.D. [2]
Synonyms and keywords: Septicaemia; sepsis syndrome; septic shock
Overview
Definitions
Pathophysiology
Causes
Differentiating Sepsis from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies